# FDA Inspection 1082135 - Biomat USA Inc - February 21, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4e2f216e-49bd-4ff6-8d60-10873ee39626
Source feed: FDA_Inspections

> FDA Inspection 1082135 for Biomat USA Inc on February 21, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082135
- Company Name: Biomat USA Inc
- Inspection Date: 2019-02-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 918993 - 2015-02-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3e78a669-cbdf-462e-a241-b4cd29ab3d70)
- [FDA Inspection 760034 - 2011-12-22](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5c866318-3e7c-4d56-9abd-5ed68781da7c)

Company: https://www.keypedia.com/companies/biomat-usa-inc/a75e8427-9a83-4056-8eca-f7886b813e1e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d